Kris Jenner has spent decades at the center of American pop culture, but her latest revelation cuts through the celebrity wellness noise with surprising candor: she tried Ozempic, it made her violently ill, and she found something better. In an era when GLP-1 drugs have reshaped conversations about weight, health, and celebrity bodies, Jenner's disclosure on the SHE MD Podcast this week offers a rare, granular look at what actually happens when a high-profile figure experiments with the most talked-about drug in years — and walks away.
Kris Jenner's Ozempic Admission: What She Actually Said
On Tuesday, May 5, 2026, Kris Jenner appeared on the SHE MD Podcast, hosted by OB-GYN Dr. Thaïs Aliabadi and wellness entrepreneur Mary Alice Haney. The conversation, which covered Jenner's extensive approach to health and longevity at 70, took a pointed turn when the topic of Ozempic came up.
Jenner confirmed she had experimented with semaglutide — the active ingredient in Ozempic and Wegovy — well before it became a household name and a cultural flashpoint. Her verdict was unambiguous. According to reporting from Her.ie, Jenner described it as making her "really sick," with nausea so severe it was professionally debilitating.
"I can't work anymore. I can't, I'm so sick. I can't like — nauseous."
That quote, directed at Dr. Aliabadi, who is also Jenner's personal physician, captures the immediate consequence: a side effect profile that made the drug effectively unusable for her lifestyle. Jenner is 70 years old, still managing one of the most active entertainment empires in the industry, and the idea of being incapacitated by nausea was, apparently, a non-starter.
The Nausea Problem: Why Ozempic Hits Some People Harder
Jenner's experience is far from unique, though the celebrity context makes it newly visible. Gastrointestinal side effects are the most commonly reported adverse reactions to GLP-1 receptor agonists like semaglutide. Nausea affects anywhere from 15 to 44 percent of users in clinical trials, with vomiting, diarrhea, and abdominal pain trailing closely behind.
The mechanism is direct: semaglutide slows gastric emptying, meaning food stays in the stomach longer. This is partly responsible for the satiety effect that makes the drug useful for weight management, but it's also the reason so many users feel persistently queasy, particularly in the early weeks. For some patients, titrating the dose slowly helps. For others, the nausea never fully resolves.
As reported by Tyla, Jenner tried the drug before widespread awareness of these side effects had entered the mainstream conversation — meaning she was experimenting at a time when the cultural roadmap for managing them was far less developed. There were no widespread patient forums, no standardized titration protocols in general practice, and no widely available anti-nausea adjunct protocols the way some clinics now offer.
The severity of Jenner's reaction — describing it as rendering her unable to work — suggests she was among the cohort for whom the side effects don't simply fade. For those individuals, discontinuation is often the only practical option, and the real question becomes: what next?
The Alternative Protocol: Peptide Injections, Supplements, and Omega-3s
Rather than returning to Ozempic or trying another GLP-1 drug, Jenner and Dr. Aliabadi worked together to build an alternative approach. The regimen, as described on the podcast, centers on three pillars: peptide injections, targeted supplements, and Omega-3 Fish Oil Supplements.
Peptide injections have grown significantly in wellness and longevity circles over the past several years. Peptides are short chains of amino acids that signal various biological processes — from growth hormone secretion to cellular repair to metabolic regulation. Specific peptides like BPC-157, CJC-1295, and ipamorelin have become popular in functional medicine for their reported effects on energy, recovery, and body composition, though it's worth noting that clinical evidence for many of these applications remains in earlier stages compared to pharmaceutical-grade GLP-1 drugs.
Coverage from MSN describes Jenner calling this alternative regimen a "game changer" — particularly for its effect on her energy levels. She noted that the combination gave her additional vitality in the evenings, extending her productive hours by what she described as "an extra couple of hours." For someone with Jenner's schedule, that's a meaningful operational gain.
The inclusion of Omega-3 Fish Oil Supplements aligns with an extensive body of research supporting their role in cardiovascular health, inflammation reduction, cognitive function, and metabolic support. Fish oils are among the most studied nutritional supplements in existence, and their inclusion in Jenner's protocol reflects a functional medicine philosophy that stacks multiple low-risk, high-evidence interventions rather than relying on a single pharmacological solution.
Quarterly Blood Work and Hormone Optimization: The Foundation of Jenner's Health Approach
What distinguishes Jenner's health strategy from casual wellness trends is the systematic monitoring underneath it. Reports confirm that Jenner has blood drawn every three months to track her hormonal profile and adjust her regimen accordingly — a practice she says she began prioritizing after age 45.
Quarterly blood panels in functional and longevity medicine typically include a comprehensive metabolic panel, complete blood count, thyroid function, sex hormones (estrogen, progesterone, testosterone), DHEA-S, cortisol, insulin, and inflammatory markers like CRP and homocysteine. The data from these panels informs micro-adjustments to supplementation, hormone therapy, and lifestyle interventions in a way that a once-a-year physical simply cannot.
Starting this protocol at 45 is notable. That's typically when perimenopausal changes begin to accelerate, when hormonal fluctuations become more pronounced, and when proactive management has the highest return on investment in terms of long-term health outcomes. Jenner's decision to begin systematic monitoring at that inflection point, rather than waiting for symptoms to become severe, reflects a genuinely forward-thinking approach to women's health — one that Dr. Aliabadi, as a specialist in women's health, is well-positioned to guide.
As noted in broader coverage of the interview, Jenner's willingness to discuss the mechanics of her health regimen publicly — blood draws, peptides, supplements — represents a break from the opacity that typically surrounds celebrity wellness. The default celebrity response to questions about appearance and health is vague deflection. Jenner gave specifics.
What This Means: Ozempic, Celebrity Transparency, and the Limits of Trend-Chasing
Jenner's disclosure lands at an important cultural moment. The GLP-1 drug category — Ozempic, Wegovy, Mounjaro, Zepbound — has dominated health and entertainment coverage for the past three years. The implicit narrative around celebrity use has often been one of either denial or enthusiastic endorsement, with very little nuance about adverse experiences.
When a figure with Jenner's cultural reach says openly that Ozempic made her too sick to work, it punctures a specific mythology: that GLP-1 drugs are a seamless, universally accessible solution. They're not. The drugs carry real side effect profiles, and for a meaningful percentage of users, those side effects are disqualifying.
There's a secondary implication worth examining. Jenner tried Ozempic "when no one knew what it was" — meaning she was early to the drug, likely through access to cutting-edge medical care that isn't available to most people. The fact that even with elite medical supervision she couldn't tolerate it underscores that tolerability is biological, not a function of access or willpower.
Her pivot to peptide injections and supplements also signals a broader trend in high-end wellness: a shift from pharmaceutical dependency toward bioidentical and peptide-based protocols that aim to optimize the body's own systems rather than override them. This approach is more labor-intensive, more personalized, and significantly harder to standardize — which is precisely why it lives in the functional medicine space rather than primary care.
For the majority of people who don't have access to quarterly hormone panels and physician-supervised peptide protocols, the practical takeaway is more modest but still useful: if a prescribed medication's side effects are severe enough to impact your daily functioning, that's a legitimate reason to stop and explore alternatives in consultation with a doctor, not a personal failure.
Kris Jenner at 70: A Different Kind of Health Conversation
Jenner's broader health narrative — the quarterly blood draws, the personalized supplementation, the peptide protocols — reflects what longevity-focused medicine increasingly recommends: continuous, data-driven management rather than reactive crisis care. The approach she describes is sometimes called "proactive health optimization," and while it remains expensive and access-limited, its core principles (regular biomarker monitoring, hormone management, anti-inflammatory supplementation) are becoming more widely discussed.
At 70, Jenner is genuinely visible evidence of what a sustained, proactive approach can look like — not as an advertisement for any particular product, but as a data point in the larger conversation about how women can navigate the post-menopausal decades. Her openness about the mechanics, including failures like Ozempic, makes the conversation more honest and ultimately more useful than the typical celebrity "I just drink water and sleep well" deflection.
The energy gains she reports from her current regimen — extra hours of productivity in the evening — matter not just as a vanity metric but as a genuine quality-of-life indicator. Sleep quality, energy levels, and cognitive clarity are increasingly recognized as central to long-term health outcomes, not peripheral lifestyle perks.
Frequently Asked Questions
Why did Kris Jenner stop taking Ozempic?
Jenner stopped taking Ozempic because it caused severe nausea that left her unable to work. She described the experience to her doctor, Dr. Thaïs Aliabadi, saying: "I can't work anymore. I can't, I'm so sick. I can't like — nauseous." She tried the drug before it became widely known and found the side effects too debilitating to continue.
What is Kris Jenner taking instead of Ozempic?
After stopping Ozempic, Jenner transitioned to a regimen developed with her personal physician that includes peptide injections, targeted supplements, fish oils, and Omega-3 Fish Oil Supplements. She has described this combination as a "game changer" that gives her additional energy and extends her productive hours in the evening.
When did Kris Jenner reveal her Ozempic experience?
Jenner made the disclosure during her appearance on the SHE MD Podcast on Tuesday, May 5, 2026. The podcast is hosted by Dr. Thaïs Aliabadi, who is also Jenner's personal physician, and Mary Alice Haney. News coverage of the revelation picked up widely on May 8, 2026.
How does Kris Jenner monitor her health?
Jenner gets her blood drawn every three months to track her hormonal profile and adjust her health regimen accordingly. She began this practice after age 45, coinciding with perimenopause, and has continued it as a foundational part of her approach to health management at 70.
Are Ozempic's nausea side effects common?
Yes. Nausea is the most commonly reported side effect of semaglutide (the active ingredient in Ozempic and Wegovy), affecting a significant percentage of users in clinical trials. It results from the drug slowing gastric emptying, which creates satiety but also causes gastrointestinal discomfort. Many users experience improvement over time, but for some patients, like Jenner, the nausea is persistent and severe enough to require discontinuation.
The Bottom Line
Kris Jenner's Ozempic revelation is significant not because it's scandalous, but because it's specific. She didn't hedge, she didn't deflect, and she didn't pretend the experience was something other than what it was: a failed experiment that she stopped, investigated, and replaced with something that actually worked for her body.
In a wellness media landscape full of aspirational claims and carefully curated health narratives, there's genuine value in a 70-year-old public figure saying: this drug made me too sick to function, so I found a different way. The alternative she found — peptide protocols, systematic hormone monitoring, Omega-3 Fish Oil Supplements — won't be accessible to everyone, but the underlying principle is universal: side effects that compromise your daily life are a legitimate reason to change course, and there are usually other paths worth exploring.
The broader conversation about GLP-1 drugs and celebrity health is only going to intensify as these medications become more mainstream. Jenner's candor adds a necessary note of complexity to that conversation — one that doesn't fit neatly into either the evangelical pro-Ozempic narrative or the dismissive backlash against it, and is more useful for that reason.
